Article Sidebar

Submitted
May 28, 2021
Published
May 28, 2021
Download
PDF
Statistic
Read Counter : 96 Download : 56

Main Article Content

Abstract

The complex and multifactorial pathogenesis of peptic ulcer has been studied over several decades, and results from an imbalance of aggressive gastric luminal factors acid and pepsin and defensive mucosal barrier function. Several environmental and host factors contribute to ulcer formation by increasing gastric acid secretion or weakening the mucosal barrier. Among environmental factors, smoking, excessive alcohol use, and drug use are most often quoted but none of them, apart from non-steroidal anti-inflammatory drugs (NSAID) use, were identified as an individual ulcerogenic agent. Emotional stress and psychosocial factors are frequently identified as important contributors to ulcer pathogenesis. Although stress cannot be neglected as a contributing factor, convincing evidence for it being the sole cause of duodenal ulcer is scarce. Aim of the present study is to evaluate the antiulcer activity of aqueous extract of Emblica officinalis (EO) on Pylorus ligated (Shay) rats model for ulcer. Additionally the muco protective effect also studied by aspirin-induced ulcerogenesis in pylorus ligated rats as the aqueous ethanolic extract reported as muco protective.

Keywords

Emblica officinalis Peptic Ulcer Aspirin Experimental Rats

Article Details

How to Cite
Muthukumar. A, G.Nagaraja Perumal, S.Mohan, R.Sundharaganapathy, D.Ranjith Kumar, & Prakash.G. (2021). Antiulcerogenic Activity on Aqueous Crude Extract of Emblica Officinalis Gaerth in Pylorus Ligated (Shay) Rats. International Journal of Research in Pharmacology & Pharmacotherapeutics, 5(4), 298-305. https://doi.org/10.61096/ijrpp.v5.iss4.2016.298-305
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1]. Susser, M., Stein, Z. Civilisation and peptic ulcer. Lancet. 279, 1962, 116–119.
  2. [2]. Parmar, N. S., Desai, J. K. A review of the current methodology for evaluation of gastric and duodenal antiulcer agents. Indian Journal of Pharmacology. 25, 1993, 120-135.
  3. [3]. Malfertheiner, P., Megraud, F., O’Morain, C. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56, 2007, 772-81.
  4. [4]. Piper, J. M., Ray, W. A., Daugherty, J. R., Griffin, M. R. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med. 114, 1991, 735–40.
  5. [5]. Gabriel, S. E., Jaakkimainen, L., Bombardier, C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 115, 1991, 787–96.
  6. [6]. Sairam, K, Rao C. V., Babu, M. D., Kumar. V. K., Agarwal, V. K., Goel, R. K. Antiulcerogenic effect of ethanolic extract of emblica officinalis: An experimental study. J Ethnopharmacol. 82, 2002, 1-9.
  7. [7]. Isenberg, J.I., McQuid, K.R., Laine, L., Rubin, W. Acid-peptic disorders. In: Yamada, T., Alpers, D.H., Ozyang, C., Powell, D.W., Silverstein, F.E. (Eds.), Textbook of Gasteroenterology. J.B. Lippincott, Philadelphia, 1991, pp. 1241–1339.
  8. [8]. Kokate CK, Purohit, Gokhale SB, ''Phytochemcial Test, In; Pharmacognosy'' Nirali Prakashan, Pune India, 1996.510-512.
  9. [9]. Balaraman R, Bafana PA, ''Anti ulcer and Anti oxidant activity of pepticare, a herbomineral formulation'', phytomedicine.12, 2005, 264-270.
  10. [10]. Shay, M., Kamarov, S.A., Fels, D., Meranze, D., Gruenstein, H., Siplet, H. A simple method for the uniform production of gastric ulceration in the rats. Gastroenterology. 5, 1945, 43–61.
  11. [11]. Mallika Jainu Gastro Protective of Cissus quadrangularis extract in rats with experimentally induced ulcer Indian J Med Res 123, June 2006 pp 799-806.
  12. [12]. Parmar, N. S., Desai, J. K. A review of the current methodology for evaluation of gastric and duodenal antiulcer agents. Indian Journal of Pharmacology. 25, 1993, 120-135.
  13. [13]. Muthukumar. A, Periyasamy .M, Manoharan, Chinnaraja.R and Anand.G. Ulcer protective and spasmolytic activity of aqueous extract of solanum nigrum leaves in experimental rats. International journal for pharmaceutical research scholars. 2, I-3, 2013, 103-110.
  14. [14]. Piper, J. M., Ray, W. A., Daugherty, J. R., Griffin, M. R. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med. 114, 1991, 735–40.
  15. [15]. Daas, M., Gupta, M. P. Gupta, G. P., Bhargava, K. P. Biogenic amines in the pathogenesis of gastric ulceration induced by aspirin in rats, Indian J.Med. Res. 65, 1977, 273.
  16. [16]. Wallace, J. L. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn’t the stomach digest itself? Physiol Rev. 88, 2008, 1547–65.
  17. [17]. Wallace, J. L., Keenan, C. M., Granger, D. N. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol. 259, 1990, G462–67.
  18. [18]. Fiorucci, S., Distrutti, E., Santucci, L. NSAIDs, Coxinbs CINOD and H2S-releasing NSAIDs, what lies beyond the horizon? Dig Liver Dis. 39, 2007, 1043–51.
  19. [19]. Green, F. W., Kaplan, M. M., Curtis, L. E., Levine, P. H. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastro duodenal mucosal hemorrhage. Gastroenterology 74, 1978, 38–43.
  20. [20]. Gabriel, S. E., Jaakkimainen, L., Bombardier, C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 115, 1991, 787–96.
  21. [21]. Daas, M., Gupta, M. P. Gupta, G. P., Bhargava, K. P. Biogenic amines in the pathogenesis of gastric ulceration induced by aspirin in rats, Indian J.Med. Res. 65, 1977, 273.
  22. [22]. Lanza, F. L., Chan, F. K., Quigley, E. M. Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 104, 2009, 728–38.
  23. [23]. Dharmani, P., Palit, G. Exploring Indian medicinal plants for antiulcer activity. Indian J Pharmacol. 38, 2006, 95-9.
  24. [24]. Lanas, A., Panes, J., Pique, J. M. Clinical implications of COX-1 and/or COX-2 inhibition for the distal gastrointestinal tract. Curr Pharm Des. 9, 2003, 2253–2266.
  25. [25]. Levenstein, S. Bellyaching in these pages: upper gastrointestinal disorders in psychosomatic medicine. Psychosom Med. 64, 2002, 767–72.
  26. [26]. Kato, I., Nomura, A. M., Stemmermann, G. N., Chyou, P. H. A prospective study of gastric and duodenal ulcer and its relation to smoking, alcohol, and diet. Am J Epidemiol. 135, 1992, 521–30.
  27. [27]. Laine, L., Maller E. S., Yu, C., Quan, H., Simon, T. Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial. Gastroenterology 127, 2004, 395–402.
  28. [28]. Hawkey, C. J. Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 119, 2000, 521–535.
  29. [29]. Green, F. W., Kaplan, M. M., Curtis, L. E., Levine, P. H. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastro duodenal mucosal hemorrhage. Gastroenterology 74, 1978 38–43.
  30. [30]. Grossman, M. I. Abnormalities of acid secretion in patients with duodenal ulcer. Gastroenterology 75, 1978, 524–26.
  31. [31]. Sairam, K, Rao C. V., Babu, M. D., Kumar. V. K., Agarwal, V. K., Goel, R. K. Antiulcerogenic effect of ethanolic extract of emblica officinalis: An experimental study. J Ethnopharmacol 82, 2002, 1-9.
  32. [32]. Bolton, J.P., Palmer, D., Cohen, M.M. Stimulation of mucus and nonparietal cell secretion by the E2 prostaglandins. Digestive Diseases Science 23, 1978, 359–364.